Delaney Mark's Insider Trades & SAST Disclosures
Delaney Mark's most recent trade in Quest Diagnostics, Inc. was a trade of 874 Common Stock done at an average price of $175.3 . Disclosure was reported to the exchange on May 12, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Delaney Mark.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Quest Diagnostics, Inc. | Mark Delaney | SVP & Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 175.31 per share. | 12 May 2025 | 874 | 7,498 (0%) | 0% | 175.3 | 153,221 | Common Stock |
| Quest Diagnostics, Inc. | Mark Delaney | SVP & Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 175.72 per share. | 12 May 2025 | 874 | 8,372 (0%) | 0% | 175.7 | 153,579 | Common Stock |
| Quest Diagnostics, Inc. | Delaney Mark | SVP & Chief Commercial Officer | 21 Apr 2025 | 25 | 9,246 (0%) | 0% | 164.4 | 4,111 | Common Stock | |
| Quest Diagnostics, Inc. | Mark Delaney | SVP & Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 166.71 per share. | 26 Mar 2025 | 256 | 9,221 (0%) | 0% | 166.7 | 42,678 | Common Stock |
| Quest Diagnostics, Inc. | Mark Delaney | SVP & Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 173.74 per share. | 04 Mar 2025 | 5,317 | 11,300 (0%) | 0% | 173.7 | 923,776 | Common Stock |
| Quest Diagnostics, Inc. | Mark Delaney | SVP & Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 173.74 per share. | 04 Mar 2025 | 1,823 | 9,477 (0%) | 0% | 173.7 | 316,728 | Common Stock |
| Quest Diagnostics, Inc. | Mark Delaney | SVP & Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 171.75 per share. | 26 Feb 2025 | 214 | 5,983 (0%) | 0% | 171.8 | 36,755 | Common Stock |
| Quest Diagnostics, Inc. | Mark Delaney | SVP & Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 169.71 per share. | 19 Feb 2025 | 242 | 6,197 (0%) | 0% | 169.7 | 41,070 | Common Stock |
| Quest Diagnostics, Inc. | Mark Delaney | SVP & Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 6,960 | 6,960 | - | - | Non-Qualifed Stock Option (right to buy) | |
| Quest Diagnostics, Inc. | Mark Delaney | SVP & Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 1,815 | 6,439 (0%) | 0% | 0 | Common Stock | |
| Quest Diagnostics, Inc. | Mark Delaney | SVP & Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 164.30 per share. | 05 Feb 2025 | 403 | 4,624 (0%) | 0% | 164.3 | 66,214 | Common Stock |
| Quest Diagnostics, Inc. | Mark Delaney | SVP & Chief Commercial Officer | 29 Jan 2025 | 4 | 5,027 (0%) | 0% | 158 | 632 | Common Stock | |
| Quest Diagnostics, Inc. | Mark Delaney | SVP & Chief Commercial Officer | 21 Oct 2024 | 4 | 5,023 (0%) | 0% | 149.5 | 598 | Common Stock | |
| Quest Diagnostics, Inc. | Mark Delaney | SVP & Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 143.08 per share. | 24 Jul 2024 | 420 | 5,019 (0%) | 0% | 143.1 | 60,094 | Common Stock |
| Quest Diagnostics, Inc. | Mark Delaney | SVP & Chief Commercial Officer | 24 Jul 2024 | 6 | 5,439 (0%) | 0% | 147 | 882 | Common Stock | |
| Quest Diagnostics, Inc. | Mark Delaney | SVP & Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 128.11 per share. | 26 Mar 2024 | 170 | 5,433 (0%) | 0% | 128.1 | 21,779 | Common Stock |
| Quest Diagnostics, Inc. | Mark Delaney | SVP & Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 126.36 per share. | 28 Feb 2024 | 225 | 5,603 (0%) | 0% | 126.4 | 28,431 | Common Stock |
| Quest Diagnostics, Inc. | Delaney Mark | SVP & Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 9,783 | 9,783 | - | - | Non-Qualifed Stock Option (right to buy) | |
| Quest Diagnostics, Inc. | Mark Delaney | SVP & Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 2,348 | 5,828 (0%) | 0% | 0 | Common Stock | |
| Quest Diagnostics, Inc. | Mark Delaney | SVP & Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 134.25 per share. | 24 Mar 2023 | 170 | 3,480 (0%) | 0% | 134.3 | 22,823 | Common Stock |
| Quest Diagnostics, Inc. | Mark Delaney | SVP & Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 7,584 | 7,584 | - | - | Non-Qualifed Stock Option (right to buy) | |
| Quest Diagnostics, Inc. | Mark Delaney | SVP & Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 1,919 | 3,650 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges